发明名称
摘要 <p>NEW MATERIAL:A compound expressed by formula I (R is ethyl or propyl). EXAMPLE:11beta,17alpha-Dihydroxy-21-chloro-pregn-4-ene-3,20-dione 17-butyrate. USE:A local anti-inflammatory agent. PROCESS:Hydrocortisone is dissolved in DMF and reacted with p-toluenesulfonyl chloride at room temperature to form 21-chlorohydrocortine, which is then reacted with trimethylchlorosilane to protect the hydroxyl group at the 11-position by trimethylsilylation. Butyric anhydride, benzene and p-toluenesulfonic acid are added and refluxed to acylate the 17-position, and the compound expressed by formula II (R' is acyl, nitro or trimethylsilyl) is obtained. The protecting group of the hydroxyl group at the 11-position is eliminated by mild hydrolysis with an acid to afford the compound of formula I.</p>
申请公布号 JPS58439(B2) 申请公布日期 1983.01.06
申请号 JP19800056001 申请日期 1980.04.26
申请人 TAISHO PHARMA CO LTD 发明人 KAMANO NORIAKI;SAWADA JIRO
分类号 C07J7/00;A61K31/57;A61P29/00 主分类号 C07J7/00
代理机构 代理人
主权项
地址